138 related articles for article (PubMed ID: 15663328)
1. Bacteria in the treatment of cancer.
Lin J; Lin E; Nemunaitis J
Curr Opin Mol Ther; 2004 Dec; 6(6):629-39. PubMed ID: 15663328
[TBL] [Abstract][Full Text] [Related]
2. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
3. Use of bacteria in anti-cancer therapies.
Ryan RM; Green J; Lewis CE
Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
[TBL] [Abstract][Full Text] [Related]
4. Bacterial vectors and delivery systems in cancer therapy.
Gardlik R; Fruehauf JH
IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592
[TBL] [Abstract][Full Text] [Related]
5. Development of bacterial vectors for tumor-targeted gene therapy.
Jia LJ; Hua ZC
Methods Mol Biol; 2009; 542():131-54. PubMed ID: 19565900
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for cancer: dairy bacteria as delivery vectors.
Tangney M
Discov Med; 2010 Sep; 10(52):195-200. PubMed ID: 20875340
[TBL] [Abstract][Full Text] [Related]
7. Bacterial gene therapy strategies.
Vassaux G; Nitcheu J; Jezzard S; Lemoine NR
J Pathol; 2006 Jan; 208(2):290-8. PubMed ID: 16362987
[TBL] [Abstract][Full Text] [Related]
8. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral strategies for the gene therapy of cancer.
Relph KL; Harrington KJ; Pandha H
Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
[TBL] [Abstract][Full Text] [Related]
10. Targeted gene-delivery strategies for angiostatic cancer treatment.
Brandwijk RJ; Griffioen AW; Thijssen VL
Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ
Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886
[TBL] [Abstract][Full Text] [Related]
12. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Bauzon M; Hermiston TW
Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
[TBL] [Abstract][Full Text] [Related]
13. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.
Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP
Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247
[TBL] [Abstract][Full Text] [Related]
14. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
[TBL] [Abstract][Full Text] [Related]
15. Bacteria in gene therapy: bactofection versus alternative gene therapy.
Pálffy R; Gardlík R; Hodosy J; Behuliak M; Resko P; Radvánský J; Celec P
Gene Ther; 2006 Jan; 13(2):101-5. PubMed ID: 16163379
[TBL] [Abstract][Full Text] [Related]
16. Viral gene therapy strategies: from basic science to clinical application.
Young LS; Searle PF; Onion D; Mautner V
J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
[TBL] [Abstract][Full Text] [Related]
17. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
Vorhies JS; Nemunaitis J
Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.
Clark JR; March JB
Trends Biotechnol; 2006 May; 24(5):212-8. PubMed ID: 16567009
[TBL] [Abstract][Full Text] [Related]
19. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
